Therapy News and Research

RSS

UF Health researcher finds simple way to treat immune-related disorder in mice

A University of Florida Health researcher has found a simple, rapid way to treat an immune-related disorder in mice, an approach that could eventually help multiple sclerosis patients after further research.

25 Nov 2015

Researchers offer novel solution to promote successful radiotherapy for cancer patients

Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have discovered a key mechanism by which radiation treatment (radiotherapy) fails to completely destroy tumors. And, in the journal Nature Immunology, they offer a novel solution to promote successful radiotherapy for the millions of cancer patients who are treated with it.

25 Nov 2015

Vitamin D supplements have no effect on frequency and severity of colds in asthma patients

Vitamin D supplements do not reduce the number or severity of colds in asthma patients, according to a new study published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

25 Nov 2015

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.

25 Nov 2015

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.

25 Nov 2015

Health insurance coverage for transgender people is cost-effective, study finds

A new analysis led by the Johns Hopkins Bloomberg School of Public Health suggests that while most U.S. health insurance plans deny benefits to transgender men and women for medical care necessary to transition to the opposite sex, paying for sex reassignment surgery and hormones is actually cost-effective.

25 Nov 2015

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.

24 Nov 2015

Molecular Dynamics to present revolutionary whole body CZT digital SPECT/CT solution at RSNA meeting

Molecular Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution at the upcoming 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America taking place in Chicago on Nov-29th through Dec-4th, in Booth 1122, Hall A.

24 Nov 2015

Vibration-based technology reduces apneic events, improves critical clinical parameters in premature infants

Scientists and clinicians at the University of Massachusetts Medical School, Wyss Institute for Biologically Inspired Engineering, and the Beth Israel Deaconess Medical Center have shown in a clinical trial that a new, vibration-based prevention technology tested in a neonatal intensive care unit (NICU) reduces apneic events and improves critical clinical parameters in prematurely born infants.

24 Nov 2015

New mathematical model forecasts metastatic breast cancer survival rates

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

Leukemia & Lymphoma Society applauds FDA's recent approval of two new multiple myeloma drugs

The Leukemia & Lymphoma Society applauds the FDA's recent approval of two new drugs -- daratumumab and ixazomib -- to treat patients with relapsed multiple myeloma. These therapies are the latest in a growing arsenal to fight this blood cancer that impacts nearly 100,000 patients in the U.S. Advances in treatments for many different types of blood cancers are happening with dizzying speed and these two approvals in just one week are the latest evidence of this phenomenon.

23 Nov 2015

New method can detect cancer cells before they form new tumor

Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).

23 Nov 2015

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

By collecting samples from the portal vein--which carries blood from the gastrointestinal tract, including from the pancreas, to the liver--physicians can learn far more about a patient's pancreatic cancer than by relying on peripheral blood from a more easily accessed vein in the arm.

23 Nov 2015

Liver's cannabinoid receptors could be targeted to combat liver cancer in some patients

A new study reveals that the liver's cannabinoid receptors could be targeted to fight liver cancer in some patients; and it offers a way to predict what treatments have the best chance of working.

23 Nov 2015

Vibration-based therapy can successfully treat apnea events in preterm infants

Researchers from Beth Israel Deaconess Medical Center's Neonatal Intensive Care Unit (NICU), the Wyss Institute for Biologically Inspired Engineering at Harvard University and the University of Massachusetts Medical School have found that a vibration-based therapy known as stochastic resonance (SR) stimulation can successfully treat preterm infants experiencing apnea of prematurity (AOP), disrupted breathing, bradycardia (slowed heart rate) and oxygen desaturation (diminished oxygen levels).

23 Nov 2015

Passive stimulation could be a promising new therapy option for pain patients

Due to disease-related changes in their brain, pain patients often suffer from an impaired tactile ability in their hands. In a pilot study conducted by scientists at the Ruhr-University Bochum, high frequency repetitive stimulation was investigated as a therapeutic approach for these patients.

23 Nov 2015

Rutgers research reveals mechanism to prevent benign kidney tumor from becoming cancerous

Research from investigators at Rutgers Cancer Institute of New Jersey examining the inner workings of a rare non-cancerous (benign) kidney tumor has revealed a mechanism to prevent this type of tumor from becoming cancerous (malignant).

22 Nov 2015

New research project aims at improving companion diagnostics and therapy of tumor diseases

An international team from four EU countries plans to use an innovative concept to improve the use of companion diagnostics in disease and develop new approaches to therapy in the long term. The idea is to combine the use of nanomedicines and short half-life radionuclides for imaging purposes in the living organism.

22 Nov 2015

ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector

ADM Tronics Unlimited, Inc. has announced that Angiodroid America, Inc. has withdrawn its Premarket Notification 510(k) application filed with the US Food and Drug Administration for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector").

22 Nov 2015

Therapy News and Research

UF Health researcher finds simple way to treat immune-related disorder in mice

Researchers offer novel solution to promote successful radiotherapy for cancer patients

Vitamin D supplements have no effect on frequency and severity of colds in asthma patients

Takeda receives FDA approval for NINLARO (ixazomib) capsules to treat patients with multiple myeloma

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Health insurance coverage for transgender people is cost-effective, study finds

New collaboration aims to develop novel generation artificial pancreas

Molecular Dynamics to present revolutionary whole body CZT digital SPECT/CT solution at RSNA meeting

Vibration-based technology reduces apneic events, improves critical clinical parameters in premature infants

New mathematical model forecasts metastatic breast cancer survival rates

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

Leukemia & Lymphoma Society applauds FDA's recent approval of two new multiple myeloma drugs

New method can detect cancer cells before they form new tumor

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

Liver's cannabinoid receptors could be targeted to combat liver cancer in some patients

Vibration-based therapy can successfully treat apnea events in preterm infants

Passive stimulation could be a promising new therapy option for pain patients

Rutgers research reveals mechanism to prevent benign kidney tumor from becoming cancerous

New research project aims at improving companion diagnostics and therapy of tumor diseases

ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News